Nav: Home

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes

September 03, 2020

BOSTON - (September 3, 2020) - Using cells taken from patients with type 2 diabetes and new techniques to convert them into specialized precursors of muscle cells, researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes.

Defects in insulin signaling or insulin resistance in skeletal muscle is important in type 2 diabetes, but with this new approach the researchers have uncovered the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade.

They found that while a number of proteins involved in the action of insulin were disrupted in cells originating from individuals with type 2 diabetes, the vast majority of changes detected were in proteins with largely unknown roles in metabolism or diabetes.

The findings should provide new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

The research program was led by C. Ronald Kahn MD, Chief Academic Officer, Senior Investigator and Section Head, Integrative Physiology and Metabolism at Joslin Diabetes Center, and Mary K. Iacocca Professor of Medicine at Harvard Medical School. Their full research findings are published in the journal Cell Metabolism.

Focusing on reprogrammed induced pluripotent stem cells, or iPSCs, that were derived from individuals with type 2 diabetes and healthy control subjects, the researchers managed to recreate a cell culture model with many of the features of muscle insulin resistance that occur in humans with diabetes.

They found that the cultured iPSC-derived myoblasts (an early precursor to most muscle cell types) from individuals with type 2 diabetes mirrored many of the impaired molecular responses to insulin and glucose that are seen in humans with diabetes. This included defects in glucose uptake and cellular metabolism.

Using a technique called phosphoproteomics that can measure chemical changes in many thousands of proteins simultaneously, they then found alterations in multiple pathways both within and outside the classical insulin signaling pathway in cells from individuals with type 2 diabetes compared to controls.

This included changes in the way DNA is converted to RNA and then into protein, as well as changes affecting the function and transport of many of these proteins within the cell. On that basis they suggest the work points to a new and previously unrecognized layer of potential targets for developing therapies towards type 2 diabetes.

Lead author Thiago Batista PhD said:

"Our findings point to changes on a multiplicity of pathways that are not explained by a single kinase or phosphatase whose function is to regulate cellular signaling. Finding chemical factors that can alone impact the function of multiple kinases and hence signaling pathways would be of great interest in the field."

Senior author C. Ronald Kahn added:

"While we are interested in how these newly identified pathways may contribute to disease progression, future research should also aim at better understanding how this might link to both genetic and environmental effects that increase the risks for diabetes. This will open up a whole new range of diagnostic and therapeutic possibilities for this common form of diabetes."
-end-
Other contributors to the research include Ashok Kumar Jayavelu, Nicolai J. Wewer Albrechtsen, Salvatore Iovino, Jasmin Lebastchi, Hui Pan, Jonathan Dreyfuss, Anna Krook, Juleen R. Zierath, Matthias Mann. Funding was provided by grants from the National Institutes of Health, the Mary K. Iacocca Professorship, the Swedish Research Council, the Novo Nordisk Foundation and the Sao Paulo Research Foundation. 

Reference: Batista et al. A cell-autonomous signature of dysregulated protein phosphorylation underlies muscle insulin resistance in type 2 diabetes. Cell Metabolism 2020

DOI: https://doi.org/10.1016/j.cmet.2020.08.007

About Joslin Diabetes Center

Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 16 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit http://www.joslin.org or follow @joslindiabetes | One Joslin Place, Boston, MA 617-309-2400

Joslin Diabetes Center

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Sound And Silence
Sound surrounds us, from cacophony even to silence. But depending on how we hear, the world can be a different auditory experience for each of us. This hour, TED speakers explore the science of sound. Guests on the show include NPR All Things Considered host Mary Louise Kelly, neuroscientist Jim Hudspeth, writer Rebecca Knill, and sound designer Dallas Taylor.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

Kittens Kick The Giggly Blue Robot All Summer
With the recent passing of Ruth Bader Ginsburg, there's been a lot of debate about how much power the Supreme Court should really have. We think of the Supreme Court justices as all-powerful beings, issuing momentous rulings from on high. But they haven't always been so, you know, supreme. On this episode, we go all the way back to the case that, in a lot of ways, started it all.  Support Radiolab by becoming a member today at Radiolab.org/donate.